Reticulocyte hemoglobin content to diagnose iron deficiency in children

C Brugnara1, D Zurakowski, J DiCanzio

  • 1Department of Pathology, The Children's Hospital, Harvard Medical School, Boston, Mass 02115, USA. brugnara@A1.tch.harvard.edu

JAMA
|June 22, 1999
PubMed

Insights

Early identification of iron deficiency in children is crucial. Reticulocyte hemoglobin content (CHr) is the strongest predictor for diagnosing iron deficiency and iron deficiency anemia in young children.

Area of Science:

  • Pediatrics
  • Hematology
  • Clinical Diagnostics

Background:

  • Early identification of iron deficiency in children is vital to prevent long-term health consequences.
  • Current diagnostic panels for childhood iron deficiency and anemia lack clarity on optimal indices.

Purpose of the Study:

  • To establish an effective diagnostic approach for iron deficiency and iron deficiency anemia in young children.

Main Methods:

  • Retrospective analysis of blood samples from 210 children (mean age 2.9 years) undergoing lead screening.
  • Assessed hemoglobin (Hb), iron, transferrin saturation (Tfsat), ferritin, and reticulocyte hemoglobin content (CHr).
  • Defined iron deficiency as Tfsat < 20% and iron deficiency anemia as Tfsat < 20% and Hb < 110 g/L.

Main Results:

  • 43% of children were iron deficient; 24 had iron deficiency anemia.
  • Reticulocyte hemoglobin content (CHr) and Hb levels significantly predicted iron deficiency.
  • CHr was the sole significant multivariate predictor for iron deficiency anemia (P<.001).
  • Plasma ferritin showed no predictive value (P = .97).

Conclusions:

  • Reticulocyte hemoglobin content (CHr) is the strongest predictor for diagnosing iron deficiency and iron deficiency anemia in children.
  • CHr demonstrates potential as an alternative to traditional biochemical iron studies.
Abstract